Published in Br J Radiol on December 17, 2009
Recent advances in breast cancer radiotherapy: Evolution or revolution, or how to decrease cardiac toxicity? World J Radiol (2010) 0.86
Creation of RTOG compliant patient CT-atlases for automated atlas based contouring of local regional breast and high-risk prostate cancers. Radiat Oncol (2013) 0.78
Does ultrasound provide any added value in breast contouring for radiotherapy after conserving surgery for cancer? Radiat Oncol (2015) 0.75
Helical tomotherapy and volumetric modulated arc therapy: New therapeutic arms in the breast cancer radiotherapy. World J Radiol (2016) 0.75
Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: an overview of the randomised trials. Lancet (2005) 24.57
Variability of target and normal structure delineation for breast cancer radiotherapy: an RTOG Multi-Institutional and Multiobserver Study. Int J Radiat Oncol Biol Phys (2009) 2.27
Should internal mammary lymph nodes in breast cancer be a target for the radiation oncologist? Int J Radiat Oncol Biol Phys (2000) 1.71
Definition of the supraclavicular and infraclavicular nodes: implications for three-dimensional CT-based conformal radiation therapy. Radiology (2001) 1.23
Loco-regional conformal radiotherapy of the breast: delineation of the regional lymph node clinical target volumes in treatment position. Radiother Oncol (2004) 1.22
High local recurrence risk is not associated with large survival reduction after postmastectomy radiotherapy in high-risk breast cancer: a subgroup analysis of DBCG 82 b&c. Radiother Oncol (2008) 1.08
Cross-sectional nodal atlas: a tool for the definition of clinical target volumes in three-dimensional radiation therapy planning. Radiology (1999) 1.05
Internal mammary lymphoscintigraphy. The rationale, technique, interpretation and clinical application: a review based on 848 cases. Radiology (1976) 1.01
Parasternal sonography of the internal mammary vessels: technique, normal anatomy, and lymphadenopathy. Radiology (1989) 1.01
Anatomical, clinical and radiological delineation of target volumes in breast cancer radiotherapy planning: individual variability, questions and answers. Br J Radiol (2009) 0.95
How to boost the breast tumor bed? A multidisciplinary approach in eight steps. Int J Radiat Oncol Biol Phys (2008) 0.95
Long-term outcomes in breast cancer patients with ten or more positive axillary nodes treated with combined-modality therapy: the importance of radiation field selection. Int J Radiat Oncol Biol Phys (2007) 0.88
CT-scan based localization of the internal mammary chain and supra clavicular nodes for breast cancer radiation therapy planning. Radiother Oncol (2006) 0.86
Target volume definition and target conformal irradiation technique for breast cancer patients. Acta Oncol (2000) 0.81
[Definition of nodal volumes in breast cancer treatment and segmentation guidelines]. J Radiol (2009) 0.81
Anatomical bases for the radiological delineation of lymph node areas. Upper limbs, chest and abdomen. Radiother Oncol (2007) 0.80
Value of axillary dissection in addition to lumpectomy and radiotherapy in early breast cancer. The Breast Carcinoma Collaborative Group of the Institut Curie. Lancet (1992) 5.49
Recurrence rates after treatment of breast cancer with standard radiotherapy with or without additional radiation. N Engl J Med (2001) 4.72
Age as prognostic factor in premenopausal breast carcinoma. Lancet (1993) 4.31
Infiltrating lobular carcinoma of the breast. Clinicopathologic analysis of 975 cases with reference to data on conservative therapy and metastatic patterns. Cancer (1996) 2.95
BRCA1 sequence variations in 160 individuals referred to a breast/ovarian family cancer clinic. Institut Curie Breast Cancer Group. Am J Hum Genet (1997) 1.91
Fifteen-year results of breast-conserving surgery and definitive breast irradiation for the treatment of ductal carcinoma in situ of the breast. J Clin Oncol (1996) 1.88
Primary chemotherapy for operable breast cancer: incidence and prognostic significance of ipsilateral breast tumor recurrence after breast-conserving surgery. J Clin Oncol (2001) 1.84
Familial invasive breast cancers: worse outcome related to BRCA1 mutations. J Clin Oncol (2000) 1.71
Ductal carcinoma in situ of the male breast. Analysis of 31 cases. Eur J Cancer (1997) 1.67
Prognostic factors of breast recurrence in the conservative management of early breast cancer: a 25-year follow-up. Int J Radiat Oncol Biol Phys (1989) 1.61
Neoadjuvant versus adjuvant chemotherapy in premenopausal patients with tumours considered too large for breast conserving surgery: preliminary results of a randomised trial: S6. Eur J Cancer (1994) 1.60
Postmastectomy radiotherapy: questions for the twenty-first century. J Clin Oncol (1998) 1.55
Carotid and vertebral artery dissections: three-dimensional time-of-flight MR angiography and MR imaging versus conventional angiography. Radiology (1994) 1.55
The influence of patient, tumor and treatment factors on the cosmetic results after breast-conserving therapy in the EORTC 'boost vs. no boost' trial. EORTC Radiotherapy and Breast Cancer Cooperative Groups. Radiother Oncol (2000) 1.53
No significant predictive value of c-erbB-2 or p53 expression regarding sensitivity to primary chemotherapy or radiotherapy in breast cancer. Int J Cancer (1998) 1.52
Mammographically detected, clinically occult ductal carcinoma in situ treated with breast-conserving surgery and definitive breast irradiation. Cancer J Sci Am (2006) 1.50
Male breast cancer: results of the treatments and prognostic factors in 397 cases. Eur J Cancer (1995) 1.48
Portal vein thrombosis during antineoplastic chemotherapy in children: report of five cases and review of the literature. Eur J Cancer (2004) 1.47
Potential doubling time and clinical outcome in head and neck squamous cell carcinoma treated with 70 GY in 7 weeks. Int J Radiat Oncol Biol Phys (1996) 1.46
Mucosal pigmentation after oral lichen planus treatment with topical tacrolimus. Dermatology (2005) 1.43
Breast cancer in elderly women: a retrospective analysis of combined treatment with tamoxifen and once-weekly irradiation. Int J Radiat Oncol Biol Phys (1995) 1.38
Contralateral breast cancer: annual incidence and risk parameters. J Clin Oncol (1995) 1.32
Comparison of the prognostic value of Scarff-Bloom-Richardson and Nottingham histological grades in a series of 825 cases of breast cancer: major importance of the mitotic count as a component of both grading systems. Anticancer Res (1998) 1.32
Can patient-, treatment- and pathology-related characteristics explain the high local recurrence rate following breast-conserving therapy in young patients? Eur J Cancer (2003) 1.22
Local control and survival of breast cancer treated by limited surgery followed by irradiation. Int J Radiat Oncol Biol Phys (1986) 1.21
Hepatic tumors: detection and characterization at 1-T MR imaging enhanced with AMI-25. Radiology (1994) 1.19
[Management of malignant phyllodes tumors of the breast: the experience of the Institut Curie]. Cancer Radiother (2009) 1.15
Combined proton beam radiotherapy and transpupillary thermotherapy for large uveal melanomas: a randomized study of 151 patients. Ophthalmic Res (2006) 1.15
Mammographically detected ductal carcinoma in situ of the breast treated with breast-conserving surgery and definitive breast irradiation: long-term outcome and prognostic significance of patient age and margin status. Int J Radiat Oncol Biol Phys (2001) 1.13
Second malignancies after breast cancer: the impact of different treatment modalities. Br J Cancer (2008) 1.13
Mammographically-detected ductal in situ carcinoma of the breast analyzed with a new classification. A study of 127 cases: correlation with estrogen and progesterone receptors, p53 and c-erbB-2 proteins, and proliferative activity. Semin Diagn Pathol (1994) 1.12
[Breast cancer in men: incidence and types of associated previous synchronous and metachronous cancers]. Bull Cancer (1992) 1.11
Surgical management of liver metastases from uveal melanoma: 16 years' experience at the Institut Curie. Eur J Surg Oncol (2009) 1.11
Prognostic factors in inflammatory breast cancer and therapeutic implications. Eur J Cancer (1994) 1.08
The influence of the boost in breast-conserving therapy on cosmetic outcome in the EORTC "boost versus no boost" trial. EORTC Radiotherapy and Breast Cancer Cooperative Groups. European Organization for Research and Treatment of Cancer. Int J Radiat Oncol Biol Phys (1999) 1.08
Survival in early-onset BRCA1 breast-cancer patients. Institut Curie Breast Cancer Group. Lancet (1998) 1.07
Treatment of liver metastases from uveal melanoma by combined surgery-chemotherapy. Eur J Surg Oncol (1998) 1.05
Smoothing intensity-modulated beam profiles to improve the efficiency of delivery. Med Phys (2001) 1.03
Conservative management of intraductal breast carcinoma with tumorectomy and radiation therapy. Cancer (1986) 1.03
p53 mutation as a genetic trait of typical medullary breast carcinoma. J Natl Cancer Inst (1999) 1.02
Laparoscopic unilateral ovarian transposition prior to irradiation: prospective study of 20 cases. Cancer (1996) 1.01
Tumor recurrence versus fibrosis in the irradiated breast: differentiation with dynamic gadolinium-enhanced MR imaging. Radiology (1993) 0.98
The 1951-98 experience of the Paris Institut Curie Radiopathology Unit: a preliminary report. J Radiol Prot (1999) 0.96
Proton beam therapy for iris melanomas. Eye (Lond) (2006) 0.96
Prognostic value of the S-phase fraction of breast cancers treated by primary radiotherapy or neoadjuvant chemotherapy. Ann N Y Acad Sci (1993) 0.95
Anatomical, clinical and radiological delineation of target volumes in breast cancer radiotherapy planning: individual variability, questions and answers. Br J Radiol (2009) 0.95
Conservative treatment of lower pole breast cancers by bilateral mammoplasty and radiotherapy. Eur J Surg Oncol (1998) 0.95
LMCE3 treatment strategy: results in 99 consecutively diagnosed stage 4 neuroblastomas in children older than 1 year at diagnosis. J Clin Oncol (2000) 0.95
Short and long-term effects on survival in breast cancer patients treated by primary chemotherapy: an updated analysis of a randomized trial. Breast Cancer Res Treat (1999) 0.94
Breast-conserving surgery with or without radiotherapy vs mastectomy for ductal carcinoma in situ: French Survey experience. Br J Cancer (2009) 0.93
Disseminated tumor cells and the risk of locoregional recurrence in nonmetastatic breast cancer. Ann Oncol (2009) 0.93
The addition of a boost dose on the primary tumour bed after lumpectomy in breast conserving treatment for breast cancer. A summary of the results of EORTC 22881-10882 "boost versus no boost" trial. Cancer Radiother (2008) 0.93
Topical superoxide dismutase reduces post-irradiation breast cancer fibrosis. J Cell Mol Med (2004) 0.92
Liver metastases from breast cancer: Surgical resection or not? A case-matched control study in highly selected patients. Eur J Surg Oncol (2013) 0.92
Ten-year results of breast-conserving surgery and definitive irradiation for intraductal carcinoma (ductal carcinoma in situ) of the breast. Cancer (1991) 0.92
Salvage treatment for local recurrence following breast-conserving surgery and definitive irradiation for ductal carcinoma in situ (intraductal carcinoma) of the breast. Int J Radiat Oncol Biol Phys (1994) 0.92
Presentation of axillary lymphadenopathy without detectable breast primary (T0 N1b breast cancer): experience at Institut Curie. Radiother Oncol (1989) 0.91
Low expression of bcl-2 in Brca1-associated breast cancers. Br J Cancer (2000) 0.91
ONCOPOOL - a European database for 16,944 cases of breast cancer. Eur J Cancer (2010) 0.90
Phytoestrogens after breast cancer. Endocr Relat Cancer (2001) 0.90
Radiotherapy for invasive breast cancer: guidelines for clinical practice from the French expert review board of Nice/Saint-Paul de Vence. Crit Rev Oncol Hematol (2010) 0.90
ERBB2 overexpression in breast carcinomas: no positive correlation with complete pathological response to preoperative high-dose anthracycline-based chemotherapy. Eur J Cancer (2000) 0.90
Uveal metastasis revealing lung cancer. J Fr Ophtalmol (2012) 0.89
Hepatic regenerating nodules: a mimic of recurrent cancer in children. Pediatr Radiol (2000) 0.89
[Prognostic factors for malignant uveal melanoma. Retrospective study on 2,241 patients and recent contribution of monosomy-3 research]. J Fr Ophtalmol (2006) 0.89
[Radiation-induced retinopathy]. Cancer Radiother (2002) 0.89
In vitro radiation-induced apoptosis and early response to low-dose radiotherapy in non-Hodgkin's lymphomas. Radiother Oncol (1998) 0.88
Conservative treatment of early breast cancer: prognostic value of the ductal in situ component and other pathological variables on local control and survival. Long-term results. Eur J Cancer Clin Oncol (1989) 0.88
Tumour growth kinetics assessment: added value to RECIST in cancer patients treated with molecularly targeted agents. Br J Cancer (2012) 0.87
In vivo induction of apoptosis in human lymphocytes by therapeutic fractionated total body irradiation. Br J Radiol (1995) 0.87
Characteristics and outcome of 1755 operable breast cancers in women over 70 years of age. Breast (2004) 0.87
Prognostic value of hemoglobin concentrations and blood transfusions in advanced carcinoma of the cervix treated by radiation therapy: results of a retrospective study of 386 patients. Int J Radiat Oncol Biol Phys (1989) 0.87
[Mammoplasty combined with irradiation: conservative treatment of breast cancer localized in the lower quadrant]. Ann Chir Plast Esthet (1990) 0.86
Paget's disease of the nipple without detectable breast tumor: conservative management with radiation therapy. Int J Radiat Oncol Biol Phys (1987) 0.86
Simultaneous bilateral breast carcinomas: a retrospective review of 149 cases. Int J Radiat Oncol Biol Phys (1994) 0.86
[Paget's disease of the nipple without any associated mammary tumor clinically or radiologically detectable. Apropos of 51 cases treated at the Curie Institute]. J Gynecol Obstet Biol Reprod (Paris) (1987) 0.85
[Care of severe accidental irradiation victims]. Rev Prat (1995) 0.85
Correlation between p53 gene expression and tumor-cell proliferation in oropharyngeal cancer. Int J Cancer (1994) 0.85
125I plaque brachytherapy for anterior uveal melanomas. Eye (Lond) (2004) 0.84
Pleomorphic adenoma. Am J Surg Pathol (1998) 0.84
[French national evaluation for helicoidal tomotherapy: description of indications, dose constraints and set-up margins]. Cancer Radiother (2007) 0.84
Intraabdominal desmoplastic small round cell tumor: report of a case with fine needle aspiration, cytologic diagnosis and molecular confirmation. Acta Cytol (2001) 0.84
[Breast-conserving therapy of breast cancer]. Cancer Radiother (2004) 0.83
Single dose versus fractionated total body irradiation before bone marrow transplantation: radiobiological and clinical considerations. Int J Radiat Oncol Biol Phys (1994) 0.83